|
KMID : 0383820070620020113
|
|
Tuberculosis and Respiratory Diseases
2007 Volume.62 No. 2 p.113 ~ p.118
|
|
|
Efficacy of deferoxamine on paraquat poisoning
|
|
Hur Jin-Won
Koh Youn-Suck
Oh Yeon-Mok
Lee Sang-Do
Kim Woo-Sung
Kim Dong-Soon
Kim Won-Dong
Shim Tae-Sun
Lim Chae-Man
Hong Sang-Bum
Jegal Yang-Jin
|
|
|
Abstract
|
|
|
Background:Paraquat is known to induce oxidant injury that results in multiorgan failure and lung fibrosis. Iron has been considered to play a key role in paraquat-induced oxidant lung injury. This study examined the effect of deferoxamine, an iron-chelating agent, in the treatment of paraquat poisoning.
Methods:From September, 2001 to April, 2005, 28 patients with paraquat poisoning who were admitted at a medical intensive care unit of a University-affiliated hospital, were enrolled in this study. Sixteen patients were treated according to the paraquat poisoning treatment guidelines and 12 received an intravenous infusion of deferoxamine in addition to the treatment guidelines.
Results:There were no differences between the two groups in terms of age, gender, severity of paraquat poisoning, and the time elapsed from ingestion to presentation at hospital. There was no difference in overall mortality between the two groups but the incidence of respiratory failure in the deferoxamine group was higher than in the conventional group(4/7 versus 0/9, p=0.019).
Conclusions:Deferoxamine seems to have no clinical benefit compared with the conventional treatment.
|
|
|
KEYWORD
|
|
|
Paraquat, Deferoxamine, Mortality
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|